Pyrimidinylimidazole inhibitors of p38: cyclic N-1 imidazole substituents enhance p38 kinase inhibition and oral activity
- 3 September 2001
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 11 (21) , 2867-2870
- https://doi.org/10.1016/s0960-894x(01)00570-4
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Role of p38 Mitogen-Activated Protein Kinase in Rhinovirus-Induced Cytokine Production by Bronchial Epithelial CellsThe Journal of Immunology, 2000
- SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lungAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2000
- Therapeutic potential of anti-inflammatory drugs in focal strokeExpert Opinion on Investigational Drugs, 2000
- SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin‐1Published by Wiley ,2000
- Design and Synthesis of Potent, Selective, and Orally Bioavailable Tetrasubstituted Imidazole Inhibitors of p38 Mitogen-Activated Protein KinaseJournal of Medicinal Chemistry, 1999
- p38 Mitogen-Activated Protein Kinase Inhibitors— Mechanisms and Therapeutic PotentialsPharmacology & Therapeutics, 1999
- Acquisition of Sensitivity of Stress-activated Protein Kinases to the p38 Inhibitor, SB 203580, by Alteration of One or More Amino Acids within the ATP Binding PocketPublished by Elsevier ,1998
- Regulation of stress-induced cytokine production by pyridinylimidazoles; inhibition of CSBP kinaseBioorganic & Medicinal Chemistry, 1997
- 1-Substituted 4-Aryl-5-pyridinylimidazoles: A New Class of Cytokine Suppressive Drugs with Low 5-Lipoxygenase and Cyclooxygenase Inhibitory PotencyJournal of Medicinal Chemistry, 1996
- A protein kinase involved in the regulation of inflammatory cytokine biosynthesisNature, 1994